{"schema_version":"secwatch.filing_event.v1","accession":"0001558370-22-010401","form_type":"8-K","ticker":"AYTU","cik":"0001385818","company_name":"AYTU BIOPHARMA, INC","filed_at":"2022-06-29T23:59:59+00:00","discovered_at":"2026-05-14T18:04:00.435231+00:00","generated_at":"2026-06-24T22:19:00.342570+00:00","sec_items":["5.02","9.01"],"event_type":"leadership","sentiment":"neutral","materiality_score":0.5,"calibrated_materiality_score":0.5,"confidence":"high","headline":"Aytu BioPharma appoints Vivian Liu to board of directors effective July 1, 2022","bullets":["Vivian Liu appointed to Aytu's board as independent director and member of Nominating & Corporate Governance Committee.","Liu receives initial grant of 6,500 restricted shares; one-third vests July 1, 2023, remainder over eight quarters.","Liu previously served as President/CEO/CFO of Innovus Pharmaceuticals (acquired by Aytu in Feb 2020) and other biopharma firms.","CEO Josh Disbrow highlights Liu's clinical and corporate development expertise to support company's growth strategy."],"urls":{"canonical":"https://secwatch.observer/filing/0001558370-22-010401","json":"https://secwatch.observer/filing/0001558370-22-010401.json","markdown":"https://secwatch.observer/filing/0001558370-22-010401.md","text":"https://secwatch.observer/filing/0001558370-22-010401.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/1385818/000155837022010401/0001558370-22-010401-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1385818/000155837022010401/aytu-20220624x8k.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-06-24T22:19:00.342570+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[{"claim_id":"0b83838108","claim":"Vivian Liu was appointed as Director at AYTU BIOPHARMA, INC.","evidence_excerpt":"On June 24 2022, the Board of Directors of Aytu BioPharma, Inc. (the “Company”) appointed Vivian Liu to the Board of Directors, effective July 1, 2022.","evidence_source":"SEC 8-K Item 5.02","evidence_url":"https://www.sec.gov/Archives/edgar/data/1385818/000155837022010401/0001558370-22-010401-index.htm","confidence":0.95,"family_label":"Executive change","details":[{"label":"Action","value":"appointed"},{"label":"Role","value":"Director"}],"fact_type":"executive_change"}],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}